Edition:
United Kingdom

Zhejiang Huahai Pharmaceutical Co Ltd (600521.SS)

600521.SS on Shanghai Stock Exchange

35.63CNY
23 May 2018
Change (% chg)

¥-0.14 (-0.39%)
Prev Close
¥35.77
Open
¥35.43
Day's High
¥36.33
Day's Low
¥35.25
Volume
9,396,599
Avg. Vol
8,762,091
52-wk High
¥39.39
52-wk Low
¥18.90

Chart for

About

ZHEJIANGHUAHAIPHARMACEUTICALCO., LTD is a China-based company, principally engaged in the manufacture and distribution of active pharmaceutical ingredients (APIs), intermediates and preparations. The Company's main products are classified as -pril series, -sartan series and preparations, including irbesartan tablets, paroxetine... (more)

Overall

Beta: 0.80
Market Cap(Mil.): ¥23,372.63
Shares Outstanding(Mil.): 1,042.49
Dividend: 0.18
Yield (%): 0.80

Financials

  600521.SS Industry Sector
P/E (TTM): 42.74 30.95 32.75
EPS (TTM): 0.52 -- --
ROI: 10.51 14.84 14.38
ROE: 12.79 16.34 16.07

BRIEF-Zhejiang Huahai Pharmaceutical's Preliminary 2017 Net Profit Up 26.45 Pct Y/Y

* SAYS PRELIM 2017 NET PROFIT UP 26.45 PERCENT Y/Y AT 633.29 MILLION YUAN ($101.16 million) Source text in Chinese: http://bit.ly/2Bf04WM Further company coverage: ($1 = 6.2600 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

07 Feb 2018

BRIEF-Zhejiang Huahai Pharmaceutical says fire accident in unit's warehouse

* Says fire accident has occurred at a warehouse of co's Zhejiang-based wholly owned pharmaceutical unit, on Jan. 18

19 Jan 2018

Earnings vs. Estimates